OncoNano Medicine

0 followers


OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeut... Read more

Industries

Employees

11-50

Links


Org chart

Kartik Krishnan
Chief Executive Officer
Kathy Rath
VP, Regulatory Affairs
Ruolan Han
Vice President, Nonclinical And Translational Research
Tian Zhao
Vice President, R&d
Angie Haar
Director Of Operations And Planning
Bhargavi Allu
Sr.analytical Chemist

Board & advisors

Brett Giroir
Chairman
John Dyett
Board Member
Yumin Qiu
Board Member
Charles Balch
Scientific Advisor
John Niederhuber
Scientific Advisor
Raphael Pollock
Scientific Advisor
Paul Bunn
Scientific Advisor
Alexander Eggermont
Scientific Advisor
Baran Sumer
Scientific Advisor